SGP SpyGlass Pharma, Inc. - Common Stock
$19.96
价格 · 六月 25, 2026
截至...的财报数据 五月 14, 2026
52周区间
$17–$32
19% of range
分析师评级
STRONG BUY
9 analysts
目标价
$45
+125% upside
P/E (TTM)
—
ROE
50.0%
净利润率
—
SGP 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$19.96
市值
—
P/E (TTM)
—
每股收益 (TTM)
$-17.98
营收 (TTM)
—
股息收益率
—
ROE
50.0%
负债/权益
—
52周区间
$17 – $32
SGP 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-17.98
2024-12-31
→
2025-12-31
自由现金流
$-33M
2025-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
SGP
同行中位数
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
SGP
同行中位数
ROA
-57.3%
—
ROE
50.0%
—
ROIC
41.9%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
SGP
同行中位数
Current Ratio (流动比率)
12.7
—
Quick Ratio (速动比率)
11.2
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
SGP
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
SGP
同行中位数
SGP 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
9 位分析师
- 强烈买入 5 55.6%
- 买入 3 33.3%
- 持有 1 11.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
5 位分析师 · 2026-06-27
中位数
$42.00
平均值
$45.00
← 低于所有目标
$19.96
最低
$37.00
最高
$62.00
中位数目标
$42.00
+110.4%
平均目标
$45.00
+125.5%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.18%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.69 | $-0.51 | -0.18% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| SGP | — | — | — | — | 50.0% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $29M | $20M | |
| SG&A Expense | $12M | $7M | |
| Operating Expenses | $41M | $27M | |
| Operating Income | $-41M | $-27M | |
| Interest Income | $3M | $1M | |
| Other Non-op | $2M | $-2M | |
| Pretax Income | $-40M | $-29M | |
| Income Tax | $0 | $0 | |
| Net Income | $-40M | $-29M | |
| EPS (Basic) | $-17.98 | $-16.31 | |
| EPS (Diluted) | $-17.98 | $-16.31 | |
| Shares (Basic) | 2,217,104 | 1,788,211 | |
| Shares (Diluted) | 2,217,104 | 1,788,211 | |
| EBITDA | $-41M | · |
资产负债表 18
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $96M | $16M | |
| Prepaid Expense | $901.0K | $715.0K | |
| Current Assets | $109M | $17M | |
| PP&E (Net) | $2M | $2M | |
| PP&E (Gross) | $3M | $3M | |
| Accum. Depreciation | $1M | $543.0K | |
| Other Non-current Assets | $492.0K | $453.0K | |
| Total Assets | $116M | $23M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $9M | $8M | |
| Capital Leases | $2M | $3M | |
| Total Liabilities | $10M | $11M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $6M | $4M | |
| Retained Earnings | $-105M | $-65M | |
| Stockholders' Equity | $-99M | $-60M | |
| Liabilities + Equity | $116M | $23M | |
| Shares Outstanding | 2,203,620 | 2,196,423 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $3M | $1M | |
| Deferred Tax | $-10M | $-7M | |
| Operating Cash Flow | $-33M | $-22M | |
| CapEx | $789.0K | $2M | |
| Investing Cash Flow | $-12M | $22M | |
| Stock Repurchased | $1M | $0 | |
| Net Stock Activity | $-1M | · | |
| Financing Cash Flow | $125M | $185.0K | |
| Net Change in Cash | $80M | $419.0K | |
| Taxes Paid | $1.0K | $18.0K | |
| Free Cash Flow | $-33M | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| ROA | -57.3% | · | |
| ROE | 50.0% | · | |
| ROIC | 41.9% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 12.7 | · | |
| Quick Ratio | 11.2 | · |
估值 (TTM) 1
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-40M | · |
损益表 14
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| R&D Expense | $9M | · | $6M | |
| SG&A Expense | $7M | · | $1M | |
| Operating Expenses | $15M | · | $7M | |
| Operating Income | $-15M | · | $-7M | |
| Interest Income | $2M | · | $126.0K | |
| Other Non-op | $2M | · | $-1M | |
| Pretax Income | $-14M | · | $-9M | |
| Income Tax | $0 | · | $0 | |
| Net Income | $-14M | · | $-9M | |
| EPS (Basic) | $-0.69 | · | $-3.96 | |
| EPS (Diluted) | $-0.69 | · | $-3.96 | |
| Shares (Basic) | 19,927,848 | · | 2,229,637 | |
| Shares (Diluted) | 19,927,848 | · | 2,229,637 | |
| EBITDA | $-15M | · | · |
资产负债表 18
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $239M | $96M | · | |
| Prepaid Expense | $2M | $901.0K | · | |
| Current Assets | $253M | $109M | · | |
| PP&E (Net) | $3M | $2M | · | |
| PP&E (Gross) | $4M | $3M | · | |
| Accum. Depreciation | $1M | $1M | · | |
| Other Non-current Assets | $789.0K | $492.0K | · | |
| Total Assets | $258M | $116M | · | |
| Accounts Payable | $4M | $3M | · | |
| Current Liabilities | $7M | $9M | · | |
| Capital Leases | $2M | $2M | · | |
| Total Liabilities | $8M | $10M | · | |
| Common Stock | $0 | $0 | · | |
| Paid-in Capital | $369M | $6M | · | |
| Retained Earnings | $-119M | $-105M | · | |
| Stockholders' Equity | $250M | $-99M | · | |
| Liabilities + Equity | $258M | $116M | · | |
| Shares Outstanding | 33,432,555 | 2,203,620 | · |
现金流 8
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Stock-based Comp | $2M | · | $345.0K | |
| Operating Cash Flow | $-14M | · | $-8M | |
| CapEx | $676.0K | · | $164.0K | |
| Investing Cash Flow | $-2M | · | $-164.0K | |
| Financing Cash Flow | $158M | · | $50M | |
| Net Change in Cash | $143M | · | $42M | |
| Taxes Paid | $0 | · | $4.0K | |
| Free Cash Flow | $-14M | · | · |
盈利能力 3
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| ROA | -10.7% | · | · | |
| ROE | -11.1% | · | · | |
| ROIC | -6.2% | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 38.0 | · | · | |
| Quick Ratio | 35.8 | · | · |
估值 (TTM) 5
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Market Cap | $866M | · | · | |
| P/B | 3.5 | · | · | |
| P / Tangible Book | 3.5 | · | · | |
| P / Cash Flow | -64.0 | · | · | |
| P / FCF | -60.9 | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| 净收入 | $-40M | $-29M |
| 稀释后每股收益 (EPS) | $-17.98 | $-16.31 |
资产负债表
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| 流动比率 | 12.7 | — |
| 速动比率 | 11.2 | — |
现金流
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| 自由现金流 | $-33M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。